US2021267945A1PendingUtilityA1

Drug compositions

68
Assignee: ADAMIS PHARMACEUTICALS CORPPriority: Aug 11, 2016Filed: May 14, 2021Published: Sep 2, 2021
Est. expiryAug 11, 2036(~10.1 yrs left)· nominal 20-yr term from priority
A61P 33/10A61K 31/4184A61K 9/1641C08B 3/06A61K 9/10A61K 2300/00A61K 47/38A61K 31/4439A61P 1/04A61K 47/10A61K 45/06C01D 5/14A61K 9/0053C08L 1/286A61K 9/145A61K 9/0095A61K 47/02A61K 9/1652C01D 7/10A61K 9/08
68
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Described herein are pharmaceutical compositions including a proton pump inhibitor and an antiparasitic drug. Methods using the compositions are also described.

Claims

exact text as granted — not AI-modified
We claim: 
     
         1 . A treatment system including:
 an oral syringe including a composition including omeprazole and fenbendazole in a melted base agent.   
     
     
         2 . The treatment system of  claim 1 , further including a wetting agent. 
     
     
         3 . The treatment system of  claim 2 , wherein the wetting agent is a polyethylene glycol. 
     
     
         4 . The treatment system of  claim 1 , further including sodium sulfite, sodium bicarbonate, or a combination thereof. 
     
     
         5 . The treatment system of  claim 1 , further including carboxymethyl cellulose. 
     
     
         6 . The treatment system of  claim 1 , further including a flavoring agent. 
     
     
         7 . The treatment system of  claim 1 , wherein the melted base agent is carboxymethyl cellulose. 
     
     
         8 . The treatment system of  claim 1 , wherein the oral syringe is a dial-a-dose oral syringe. 
     
     
         9 . The treatment system of  claim 1 , wherein the oral syringe is a 30 mL oral syringe. 
     
     
         10 . A method of increasing performance of a mammal, the method comprising:
 administering a composition including omeprazole and fenbendazole formulated in a melted base agent to the mammal, and   increasing the performance.   
     
     
         11 . The method of  claim 10 , wherein the administration is oral. 
     
     
         12 . The method of  claim 10 , wherein the administration is ingestion. 
     
     
         13 . The method of  claim 10 , wherein the administration is inhalation. 
     
     
         14 . The method of  claim 10 , wherein the mammal is an athlete. 
     
     
         15 . The method of  claim 14 , wherein the athlete is a race horse, race camel, race dog, racing human, jumping horse, jumping camel, jumping dog, jumping human, dancing horse, dancing camel, dancing dog, or dancing human. 
     
     
         16 . The method of  claim 10 , wherein the mammal is a humans, horse, camel, dog, cat, cow, bear, rodent, oxen, bison, buffalo, caribou, moose, deer, elk, sheep, goat, pig, rabbit, pouched mammal, primate, or carnivore. 
     
     
         17 . The method of  claim 10 , wherein the administering is for less than about 30 days. 
     
     
         18 . The method of  claim 10 , wherein the administering is for less than about 14 days. 
     
     
         19 . The method of  claim 10 , wherein the administering is once daily. 
     
     
         20 . The method of  claim 10 , wherein the administering is twice daily.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.